324 related articles for article (PubMed ID: 33731589)
1. Prevention of variceal rebleeding in cirrhotic patients with spontaneous portosystemic shunts: transjugular intrahepatic portosystemic shunt versus endoscopic treatment.
Zhang H; Xiao J; Tu J; Zhang M; Zhang F; Yin Q; Zhuge Y
Eur J Gastroenterol Hepatol; 2021 May; 33(5):752-761. PubMed ID: 33731589
[TBL] [Abstract][Full Text] [Related]
2. Portosystemic shunts versus endoscopic intervention with or without medical treatment for prevention of rebleeding in people with cirrhosis.
Simonetti RG; Perricone G; Robbins HL; Battula NR; Weickert MO; Sutton R; Khan S
Cochrane Database Syst Rev; 2020 Oct; 10(10):CD000553. PubMed ID: 33089892
[TBL] [Abstract][Full Text] [Related]
3. Surgical portosystemic shunts versus transjugular intrahepatic portosystemic shunt for variceal haemorrhage in people with cirrhosis.
Brand M; Prodehl L; Ede CJ
Cochrane Database Syst Rev; 2018 Oct; 10(10):CD001023. PubMed ID: 30378107
[TBL] [Abstract][Full Text] [Related]
4. Endoscopic therapy + β-blocker vs. covered transjugular intrahepatic portosystemic shunt for prevention of variceal rebleeding in cirrhotic patients with hepatic venous pressure gradient ≥16 mmHg.
Guo H; Zhang F; Yin X; Zhang M; Xiao J; Wang Y; Zhang B; Zhang W; Zou X; Zhuge Y
Eur J Gastroenterol Hepatol; 2021 Nov; 33(11):1427-1435. PubMed ID: 32868650
[TBL] [Abstract][Full Text] [Related]
5. Association between non-variceal spontaneous portosystemic shunt and outcomes after TIPS in cirrhosis.
He C; Lv Y; Wang Z; Guo W; Tie J; Li K; Niu J; Zuo L; Yu T; Yuan X; Chen H; Wang Q; Liu H; Bai W; Wang E; Xia D; Luo B; Li X; Yuan J; Han N; Zhu Y; Wang J; Yin Z; Fan D; Han G
Dig Liver Dis; 2018 Dec; 50(12):1315-1323. PubMed ID: 29960900
[TBL] [Abstract][Full Text] [Related]
6. Covered TIPS versus endoscopic band ligation plus propranolol for the prevention of variceal rebleeding in cirrhotic patients with portal vein thrombosis: a randomised controlled trial.
Lv Y; Qi X; He C; Wang Z; Yin Z; Niu J; Guo W; Bai W; Zhang H; Xie H; Yao L; Wang J; Li T; Wang Q; Chen H; Liu H; Wang E; Xia D; Luo B; Li X; Yuan J; Han N; Zhu Y; Xia J; Cai H; Yang Z; Wu K; Fan D; Han G;
Gut; 2018 Dec; 67(12):2156-2168. PubMed ID: 28970291
[TBL] [Abstract][Full Text] [Related]
7. Comparison of transjugular intrahepatic portosystemic shunt for treatment of variceal bleeding in patients with cirrhosis with or without spontaneous portosystemic shunt.
Leng X; Zhang F; Zhang M; Guo H; Yin X; Xiao J; Wang Y; Zou X; Zhuge Y
Eur J Gastroenterol Hepatol; 2019 Jul; 31(7):853-858. PubMed ID: 30633039
[TBL] [Abstract][Full Text] [Related]
8. Eight millimetre covered TIPS does not compromise shunt function but reduces hepatic encephalopathy in preventing variceal rebleeding.
Wang Q; Lv Y; Bai M; Wang Z; Liu H; He C; Niu J; Guo W; Luo B; Yin Z; Bai W; Chen H; Wang E; Xia D; Li X; Yuan J; Han N; Cai H; Li T; Xie H; Xia J; Wang J; Zhang H; Wu K; Fan D; Han G
J Hepatol; 2017 Sep; 67(3):508-516. PubMed ID: 28506905
[TBL] [Abstract][Full Text] [Related]
9. Transjugular intrahepatic portosystemic shunt vs endoscopic therapy in preventing variceal rebleeding.
Xue H; Zhang M; Pang JX; Yan F; Li YC; Lv LS; Yuan J; Palikhe M; Li WZ; Wang ZL
World J Gastroenterol; 2012 Dec; 18(48):7341-7. PubMed ID: 23326143
[TBL] [Abstract][Full Text] [Related]
10. Balloon-compression endoscopic injection sclerotherapy versus transjugular intrahepatic portosystemic shunt for esophageal variceal rebleeding.
Wu W; Zhang F; Mei X; Zhang Q; Jin J; Kong D
Surg Endosc; 2023 Jul; 37(7):5766-5774. PubMed ID: 37147526
[TBL] [Abstract][Full Text] [Related]
11. Portosystemic shunts versus endoscopic therapy for variceal rebleeding in patients with cirrhosis.
Khan S; Tudur Smith C; Williamson P; Sutton R
Cochrane Database Syst Rev; 2006 Oct; 2006(4):CD000553. PubMed ID: 17054131
[TBL] [Abstract][Full Text] [Related]
12. Prevention of variceal rebleeding in cirrhotic patients with advanced hepatocellular carcinoma receiving molecularly targeted therapy: a randomized pilot study of transjugular intrahepatic portosystemic shunt versus endoscopic plus β-blocker.
Chen Y; Ma X; Zhang X; Luo J; An L; Zhang Y; Chang X; Dong Z; Zhang W; Kong H; Zhao J; Ding H; Liu F; Yang Y
Hepatol Int; 2022 Dec; 16(6):1379-1389. PubMed ID: 36255564
[TBL] [Abstract][Full Text] [Related]
13. Transjugular intrahepatic portosystemic shunt (TIPS) versus endoscopic variceal ligation in the prevention of variceal rebleeding in patients with cirrhosis: a randomised trial.
Pomier-Layrargues G; Villeneuve JP; Deschênes M; Bui B; Perreault P; Fenyves D; Willems B; Marleau D; Bilodeau M; Lafortune M; Dufresne MP
Gut; 2001 Mar; 48(3):390-6. PubMed ID: 11171831
[TBL] [Abstract][Full Text] [Related]
14. PTFE-covered TIPS is an effective treatment for secondary preventing variceal rebleeding in cirrhotic patients with high risks.
Zhou Y; Zhang W; Zhang Z; Luo J; Gu J; Liu Q; Ma J; Yan Z; Chen S; Wang J
Eur J Gastroenterol Hepatol; 2020 Sep; 32(9):1235-1243. PubMed ID: 32744824
[TBL] [Abstract][Full Text] [Related]
15. Early TIPS with covered stents versus standard treatment for acute variceal bleeding in patients with advanced cirrhosis: a randomised controlled trial.
Lv Y; Yang Z; Liu L; Li K; He C; Wang Z; Bai W; Guo W; Yu T; Yuan X; Zhang H; Xie H; Yao L; Wang J; Li T; Wang Q; Chen H; Wang E; Xia D; Luo B; Li X; Yuan J; Han N; Zhu Y; Niu J; Cai H; Xia J; Yin Z; Wu K; Fan D; Han G;
Lancet Gastroenterol Hepatol; 2019 Aug; 4(8):587-598. PubMed ID: 31153882
[TBL] [Abstract][Full Text] [Related]
16. Transjugular intrahepatic portosystemic shunt prevents rebleeding in cirrhotic patients having cavernous transformation of the portal vein without improving their survival.
Li LN; Sun XY; Wang GC; Tian XG; Zhang MY; Jiang KT; Zhang CQ
J Dig Dis; 2019 Feb; 20(2):89-96. PubMed ID: 30629804
[TBL] [Abstract][Full Text] [Related]
17. Clinical Efficacy of Transjugular Intrahepatic Portosystemic Shunt Created with Expanded Polytetrafluoroethylene-Covered Stent-Grafts: 8-mm Versus 10-mm.
Luo X; Wang X; Zhu Y; Xi X; Zhao Y; Yang J; Li X; Yang L
Cardiovasc Intervent Radiol; 2019 May; 42(5):737-743. PubMed ID: 30643936
[TBL] [Abstract][Full Text] [Related]
18. Transjugular intrahepatic portosystemic shunt versus endoscopic therapy in the secondary prophylaxis of variceal rebleeding in cirrhotic patients: meta-analysis update.
Zheng M; Chen Y; Bai J; Zeng Q; You J; Jin R; Zhou X; Shen H; Zheng Y; Du Z
J Clin Gastroenterol; 2008; 42(5):507-16. PubMed ID: 18344888
[TBL] [Abstract][Full Text] [Related]
19. Episodic overt hepatic encephalopathy after transjugular intrahepatic portosystemic shunt does not increase mortality in patients with cirrhosis.
Nardelli S; Riggio O; Marra F; Gioia S; Saltini D; Bellafante D; Adotti V; Guasconi T; Ridola L; Rosi M; Caporali C; Fanelli F; Roccarina D; Bianchini M; Indulti F; Spagnoli A; Merli M; Vizzutti F; Schepis F
J Hepatol; 2024 Apr; 80(4):596-602. PubMed ID: 38097113
[TBL] [Abstract][Full Text] [Related]
20. Small-Diameter Transjugular Intrahepatic Portosystemic Shunt versus Endoscopic Variceal Ligation Plus Propranolol for Variceal Rebleeding in Advanced Cirrhosis.
Wang X; Liu G; Wu J; Xiao X; Yan Y; Guo Y; Yang J; Li X; He Y; Yang L; Luo X
Radiology; 2023 Aug; 308(2):e223201. PubMed ID: 37606572
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]